North America accounts for a substantial share of the Erythrocyte Sedimentation Rate Analyzer Market, driven by the growing prevalence of inflammatory and autoimmune disorders, advanced clinical laboratory infrastructure, and widespread adoption of automated diagnostic technologies. The region benefits from strong healthcare investments, increasing demand for accurate hematology...